Balaxi Pharmaceuticals (NSE:BALAXI) Interest Expense : ₹-28 Mil (TTM As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Balaxi Pharmaceuticals Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Balaxi Pharmaceuticals's interest expense for the three months ended in Dec. 2024 was ₹ -14 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₹-28 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Balaxi Pharmaceuticals's Operating Income for the three months ended in Dec. 2024 was ₹ 35 Mil. Balaxi Pharmaceuticals's Interest Expense for the three months ended in Dec. 2024 was ₹ -14 Mil. Balaxi Pharmaceuticals's Interest Coverage for the quarter that ended in Dec. 2024 was 2.55. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Balaxi Pharmaceuticals Interest Expense Historical Data

The historical data trend for Balaxi Pharmaceuticals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Balaxi Pharmaceuticals Interest Expense Chart

Balaxi Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Interest Expense

Get a 7-Day Free Trial

-0.48

-0.18

-1.42

-5.00

-16.77

Balaxi Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial															-4.15	-6.05	-3.71	-4.51	-13.77

Balaxi Pharmaceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-28 Mil.

Balaxi Pharmaceuticals (NSE:BALAXI) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Balaxi Pharmaceuticals's Interest Expense for the three months ended in Dec. 2024 was ₹-14 Mil. Its Operating Income for the three months ended in Dec. 2024 was ₹35 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was ₹0 Mil.

Balaxi Pharmaceuticals's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2024 )	/	Interest Expense (Q: Dec. 2024 )
	=	-1	*	35.095	/	-13.773
	=	2.55

The higher the ratio, the stronger the company's financial strength is.

Balaxi Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Balaxi Pharmaceuticals Ltd (NSE:BALAXI) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

Phase-III, Road No: 81, Jubilee Hills, Plot No.409, H,No: 8-2-293, MAPS Towers, 3rd Floor, Hyderabad, TG, IND, 500 096

Website

https://www.balaxipharma.in

Balaxi Pharmaceuticals Ltd is an Indian branded IPR-based pharmaceutical company focusing on frontier markets, with a vast and growing portfolio of prescription and OTC drugs, across multiple therapeutic segments. Geographically it earns key revenue from Guatemala.

Balaxi Pharmaceuticals Headlines

No Headlines